N/A
Completed N=46
Effects of Mindfulness-Based Cognitive-Behavioral Conjoint Therapy on PTSD and Relationship Function
Source: ClinicalTrials.gov NCT01035788 ↗Enrolled (actual)
46
Serious AEs
0.0%
Results posted
Dec 2015
Primary outcomePrimary: Clinician-Administered PTSD Scale (CAPS) — 45.5; 46.2 units on a scale — p=.849
Summary
The purpose of this study is to first adapt Cognitive Behavioral Conjoint Therapy for PTSD for Operation Enduring Freedom and Operation Iraqi Freedom (OEF-OIF) Veterans diagnosed with PTSD and their intimate partners by (1) reducing the overall length of treatment from 15 weeks to 10 weeks through the use of a weekend couple retreat to deliver the first two of three phases of the three-phase protocol; and (2) by integrating mindfulness interventions as a way to mitigate the short, more condensed treatment. Secondly, this study will examine the effects of this adapted Mindfulness-Based Cognitive-Behavioral Conjoint Therapy on PTSD symptoms and intimate relationship functioning.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinician-Administered PTSD Scale (CAPS) |
45.5; 46.2 | .849 |
Eligibility Criteria
Inclusion Criteria
Veteran must:
- be enrolled in outpatient treatment
- have a confirmed diagnosis of PTSD
- have no major change in psychiatric medication for at least 1 month
- have a partner mutually committed to maintaining the relationship for the duration of the intervention
- willing to forgo initiating psychotherapy for PTSD or other conditions during the study
Exclusion Criteria
- severe physical or sexual relationship aggression in the past year
- current suicidal/homicidal intent (Veteran or partner)
- cognitive impairment that precludes understanding session content (either Veteran or partner)
- current substance dependence of Veteran or partner
- uncontrolled psychotic or bipolar disorder in Veteran or partner
- PTSD diagnosis in the partner
- self-mutilation or self-injury within the previous 6 months by Veteran or partner
- unwilling to have therapy or CAPS sessions video or audio recorded
Data sourced from ClinicalTrials.gov (NCT01035788). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.